We want to make millions of respiratory patients successful in managing their disease.

We develop an intuitive device that helps to inhale the medication correctly and deliver the optimal dose into the patient's lungs. We include healthcare providers and the patient's family to develop holistic solutions to elevate the patient's well-being. 


Studies show that 70-90% of patients perform one or more critical errors in their inhalation technique. Incorrectly inhaled medication leads to poor control of the disease and increases the number of exacerbations - sudden breathlessness attacks. 

Our three core values:

- Patients in the center

- Decisions driven by science and data 

- Viewing problems from different perspectives


Patients with Asthma and  COPD face a wide array of inhaler types to manage their disease, each requires different inhalation technique. This makes inhalers a hard-to-use devices where patients are recommended to be educated every few months to be able to inhale correctly.


We develop a medical device with a unique combination of electronic components that intuitively guides the patient through the inhalation process. The device helps patients breathe easily even though they have asthma or COPD  (Chronic Obstructive Pulmonary Disease).


 August 2021


Our team is growing!

During this summer a fantastic software developer Marcus Oscarsson from the KTH computer science program joined us to boost our digital product development. 

"This has been an exciting summer with a focus on rapid development! During the summer, I have had the opportunity to learn a lot, and it has been interesting to take part in the inner workings of such an innovative MedTech startup. Thank you to Petra, Annelie, and Essam for bringing me on board and for your dedication to helping patients!"

 Juni 2021


Artikel in HjärtLungNytt

Article in HjärtLungNytt "With help from Riksförbundet HjärtLung Stockholm and their members, we have had the opportunity to interview, get relevant feedback and increased knowledge about the use of inhalers. During the summer, the members will test our latest prototype."

Click on the icon to read the whole article.

 2 Juni 2021


Remote prototype testing

During the spring and summer, members test our latest prototype. This is a continuation of a collaboration with the Heart-Lung Association where we interviewed members in 2019 and gained very valuable insights. In the current situation, the test is developed to be carried out remotely. We look forward to the feedback so that we can continue to develop a product that is really helpful in people's everyday lives in the management of COPD.


Universities, organizations and companies around the world have chosen to support Andning Med in our journey. We’re proud to be a part of the work of forward-thinking, innovation and research.

Sting is the leading ecosystem in the Nordics for startups with high growth potential. www.sting.co

KTH innovation